Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (701-710 of 888) with videos related to

Pageof 89
Sort By:
The Oncologist|October 25, 2024
Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT studyTomasz M Beer, Daniel J George, Neal D Shore, et al.
Veterinary Microbiology|November 23, 2007
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virusE Starick, M Beer, B Hoffmann, et al.
Transboundary and Emerging Diseases|January 12, 2018
Faecal Escherichia coli as biological indicator of spatial interaction between domestic pigs and wild boar (Sus scrofa) in CorsicaS A Barth, S Blome, D Cornelis, et al.
The Prostate|October 30, 2009
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicityDavid Z Qian, Brooks L S Rademacher, Janet Pittsenbarger, et al.
Frontiers in Cell and Developmental Biology|November 25, 2021
HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-InhibitionHao Geng, Hyun-Kyung Ko, Janet Pittsenbarger, et al.
Health and Quality of Life Outcomes|June 25, 2017
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trialNancy Devlin, Michael Herdman, Marco Pavesi, et al.
Frontiers in Oncology|November 8, 2024
Pre-malignant conditions diagnosed following a positive cancer signal from a multi-cancer early detection testOmair A Choudhry, Angana B Kharge, Seema P Rego, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Pageof 89

Showing results (701-710 of 888) with videos related to

Sort By:
Pageof 89
The Oncologist|October 25, 2024
Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT studyTomasz M Beer, Daniel J George, Neal D Shore, et al.
Veterinary Microbiology|November 23, 2007
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virusE Starick, M Beer, B Hoffmann, et al.
Transboundary and Emerging Diseases|January 12, 2018
Faecal Escherichia coli as biological indicator of spatial interaction between domestic pigs and wild boar (Sus scrofa) in CorsicaS A Barth, S Blome, D Cornelis, et al.
The Prostate|October 30, 2009
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicityDavid Z Qian, Brooks L S Rademacher, Janet Pittsenbarger, et al.
Frontiers in Cell and Developmental Biology|November 25, 2021
HIF1 and ID1 Interplay Confers Adaptive Survival to HIF1α-InhibitionHao Geng, Hyun-Kyung Ko, Janet Pittsenbarger, et al.
Health and Quality of Life Outcomes|June 25, 2017
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trialNancy Devlin, Michael Herdman, Marco Pavesi, et al.
Frontiers in Oncology|November 8, 2024
Pre-malignant conditions diagnosed following a positive cancer signal from a multi-cancer early detection testOmair A Choudhry, Angana B Kharge, Seema P Rego, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
Cancer|May 12, 2006
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignanciesTomasz M Beer, Catherine M Tangen, Craig R Nichols, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Pageof 89